U UNIPHARM GLOBAL
International Healthcare Partner Science • Data • Regulation

From Science to Market

Unipharm Global Limited helps transform pharmaceutical innovations, ingredients and product concepts into compliant, market-ready healthcare solutions across Asia-Pacific.

360°

End-to-End Healthcare Commercialization

Connecting R&D, regulatory pathways, market intelligence, supply chain and commercialization into one strategic model.

AI

Market Intelligence

Forecasting, disease modeling, portfolio selection and launch planning.

REG

Regulatory Strategy

Registration planning for drugs, devices, supplements and cosmetics.

Brand Essence

Science, data and global vision in one operating platform.

Unipharm Global is built for healthcare partners that need more than distribution. We combine technical understanding, regulatory planning and market intelligence to move products from concept to commercial reality.

Brand Story

Closing the gap between innovation and access.

Many strong pharmaceutical ingredients, formulations and scientific innovations never reach patients because development pathways are fragmented, regulatory requirements are complex, and market signals are unclear.

Unipharm Global acts as the connector between international manufacturers, R&D partners, registration frameworks and local market demand.

1

Identify

Evaluate scientific assets, ingredients and healthcare opportunities.

2

Validate

Use evidence, data and regulatory mapping to reduce risk.

3

Register

Build practical pathways for product registration and market entry.

4

Commercialize

Support positioning, distribution and partnership models.

Core Values

Built for trusted long-term healthcare partnerships.

SI

Scientific Integrity

Evidence, clinical data and international standards guide decisions.

RE

Regulatory Excellence

Practical registration strategies across multiple healthcare categories.

AI

Data Leadership

Analytics and AI improve market evaluation and planning.

PM

Partnership Mindset

Flexible models for licensing, technology transfer and distribution.

GM

Global Mindset

International standards combined with local market insight.

Business Model

Five service lines across the healthcare value chain.

Unipharm Global can participate from early product evaluation through registration, launch and regional commercialization.

Pharma Ingredients & Supply Chain

Regional access model for international API and specialty ingredient manufacturers.

  • APIs, excipients and intermediates
  • Rare and high-value pharmaceutical ingredients
  • Exclusive or semi-exclusive Southeast Asia distribution
  • Trusted regional gateway for global manufacturers

R&D, BE & Technology Transfer

Technical development support for product readiness and dossier quality.

  • Formulation development and optimization
  • Zone IVa / IVb stability studies
  • Bioequivalence study coordination
  • Scale-up, validation and dossier transfer

Regulatory & Product Registration Consulting

Stepwise registration planning aligned with lifecycle and market priorities.

  • Drug, medical device, nutraceutical and cosmetic registration
  • ASEAN, PIC/S and SRA-aligned strategies
  • Lifecycle-based regulatory planning

Market Intelligence & Strategic Consulting

Data-led assessment of product fit, competition and commercial potential.

  • Therapeutic area analysis: Cardiology, CNS, Oncology, Anti-infective and more
  • Generic, branded generic, nutrition and device category analysis
  • Disease burden, pricing, reimbursement and tender mapping

Marketing & Commercialization Advisory

Go-to-market planning designed for local execution and regional scalability.

  • Product positioning and brand strategy
  • OTC, ETC, tender-based and digital distribution models
  • Licensing, co-marketing and exclusive distribution strategies
Big Data & AI Platform

Decision intelligence for product portfolios and market entry.

Our analytics layer supports forecasting, disease trend analysis, portfolio prioritization and regulatory timeline simulation.

01Market Forecasting
02Disease Trend Prediction
03Portfolio Optimization
04Regulatory Timeline Simulation
Why It Matters

Lower uncertainty before investment.

For healthcare products, market entry risk often comes from unclear demand, regulatory complexity, competition and reimbursement pressure. Data-backed planning helps partners decide faster and execute with more confidence.

  • Prioritize attractive product opportunities
  • Identify unmet medical needs and market gaps
  • Compare launch pathways and regulatory scenarios
  • Support commercial strategy with structured evidence
Geographic Focus

Asia-Pacific and emerging healthcare markets.

Unipharm Global focuses on markets where scientific innovation, regulatory execution and local access strategy can create meaningful healthcare impact.

  • Southeast Asia
  • Asia-Pacific
  • Emerging markets with high unmet medical needs

Regional Gateway

Connecting global supply, R&D, regulation and market access.

Partnership

Bring scientific healthcare assets into real markets.

Work with Unipharm Global to evaluate, register, position and commercialize healthcare products with a science-led and data-supported approach.

Contact Unipharm Global